Exchange Studies of Complexes of Co(II) with Oximes of 2-Hydroxyacetophenone, Resacetophenone & 5-Nitroresacetophenone

141-14

Specific Surface Area of Arsenic Sulphide

271-27

Viscosities of Binary Liquid Mixtures of Carbon Tetrachloride with Toluene & Xylenes

503-50

Viscosities of Binary Liquid Mixtures of 1-Propanol, 1-Butanol, 1-Pentanol & 1-Hexanol with Methylcyclohexane, Cyclopentanone & Cyclohexanone

239-24

Hydrogen Bonding & Excess Volumes of Mixing of Phenol, o- & p-Chlorophenols & 0- & p-Cresols with Tetrahydrofuran & Cyc1ohexanone

275-27

Lagrangian subcategories and braided tensor equivalences of twisted quantum doubles of finite groups

We classify Lagrangian subcategories of the representation category of a twisted quantum double of a finite group. In view of results of 0704.0195v2 this gives a complete description of all braided tensor equivalent pairs of twisted quantum doubles of finite groups. We also establish a canonical bijection between Lagrangian subcategories of the representation category of a twisted quantum double of a finite group G and module categories over the category of twisted G-graded vector spaces such that the dual tensor category is pointed. This can be viewed as a quantum version of V. Drinfeld's characterization of homogeneous spaces of a Poisson-Lie group in terms of Lagrangian subalgebras of the double of its Lie bialgebra. As a consequence, we obtain that two group-theoretical fusion categories are weakly Morita equivalent if and only if their centers are equivalent as braided tensor categories.Comment: 26 pages; several comments and references adde

Endoscopy in Renal Cancer Organ Preservation Treatments

This chapter traces the shift in treatment of localised renal cancer from major open surgery to endoscopic (ie laparoscopy) techniques. It also details the shift in treatment intent for localised Renal cancer toward Organ preservation. With advancement in technology and experience, the principles of endoscopic surgery have been adapted to treat renal malignancy with minimum complications and with maximal preservation of Renal function so much so that endoscopic techniques are seen as the “gold standard” by many. The chapter details these minimally invasive techniques of laparoscopic and Robotic partial nephrectomy and compares and contrasts both Oncological and Functional outcomes from both

Enhanced removal of nitrate in an integrated electrochemical-adsorption system

© 2017 Elsevier B.V. The electrochemical (EC) method of removing pollutants in water is a widely used process in water and wastewater treatment. An EC-adsorption integrated system was investigated to test whether the simultaneous removal of nitrate by the two processes would be better than removal utilising the individual EC and adsorption methods. In the integrated system, an adsorbent (ion exchange resin - Dowex 21k XLT) was placed inside a stainless steel box that served as an anode with a Cu plate as cathode. In an experiment using 2 L nitrate solution containing 20 mg N/L and 2 g adsorbent the rate of nitrate removal in the integrated system was initially fast with 35% removed in 30 min, though slowing down later. The rate of removal increased with increasing current, voltage and pH up to 7 but decreased as the distance between the electrodes also increased. The optimum nitrate removal of 67% was obtained at pH 7, 1 A, and 31 V for a distance of 1 cm between the electrodes after 180 min. The amount of nitrate removed fell when sulphate was present in the integrated system due to sulphate competing with nitrate for adsorption. Concentration of ammonium produced by nitrate reduction in the EC system was reduced in the presence of adsorbent. Nitrate removal in the integrated system is approximately equal to the sum of the removals in the two individual processes

POLYPHARMACY INDUCED DRUG INTERACTIONS, ADVERSE DRUG REACTIONS (ADR) AND MEDICATION ERRORS IN TERTIARY CARE SOUTH INDIAN HOSPITAL

Objective: To study the pattern of drug interactions (DI) in our hospital and to identify whether it is associated with polypharmacy. To determine the level of severity of potential drug-drug interactions (PDDI), to detect, monitor and prevention of ADRs in the hospitalized patients and to identify the medication errors (ME). Methods: A prospective interventional study was conducted in a 300 bedded tertiary care South Indian hospital for a period of 6 mo. Prescriptions were analysed for PDDI using Micromedex software 2.2. The causality and severity of ADRs were assessed by using Naranjo’s, WHO UMC Scales and Hart wigs severity scales. ME was identified by review of patient drug charts. Results: Total 190 prescriptions were analyzed, in which 1028 drug interactions were seen. Out of which 718 were DDI, 198 DFI, 100 DEI, and 12 DTI were observed. More number of DI was seen in cardiovascular drugs, antibiotics followed by antacids and antiulcer agents. A total of 52 ADRs were identified in 43 patients. Diuretics, cardiovascular drugs were associated with a higher incidence of ADRs followed by Anti-Diabetic agents. 58 ME was seen in 190 prescriptions, among them omission error, prescribing errors and Wrong dose error was seen. Conclusion: Clinical pharmacist plays a potential role in the health care system in assisting the physician i.e. modifying the number of drugs taken, number of doses taken, medication adherence, identification of drug interactions, preventing, monitoring and detection of ADRs and identifying the medication errors

Prospective, randomized double blind comparative study of safety and efficacy of carvedilol versus atenolol in patients of mild to moderate hypertension

Background: Carvedilol is a new cardiovascular compound with the combined pharmacologic properties of nonselective ß-blockade and vasodilation. The Aim of the study was to compare the safety and antihypertensive efficacy of 25mg Carvedilol once daily with 50mg atenolol once daily in patients with mild to moderate essential hypertension.Methods: This was a single center study conducted in Rangaraya Medical College, Kakinada. 80 eligible patients with mild to moderate hypertension were randomized to receive 25mg Carvedilol once daily (40 patients) or 50mg atenolol (40 patients) in a double-blind 12-week treatment phase. At each visit 0, 4, 8 and 12 weeks of treatment, sitting Blood Pressure (BP) and heart rate were measured. The effect on BP reduction within the group is compared by paired “t”test and the effect on reduction of BP between two study groups compared by unpaired “t”test.Results: After 12 weeks of treatment, the mean reduction of SBP (Systolic Blood Pressure) with carvedilol is 22.33±8.31mmHg with no Significant difference (p >0.05) compared to atenolol group mean reduction in SBP of 21.37±10mm Hg. The mean reduction in DBP (Diastolic Blood Pressure) after completion of the study in carvedilol group is 6.75±4.82mm Hg with no Significant difference (p >0.05) compared to atenolol group mean reduction in DBP of 8.55±5.25mm Hg. No significant difference seen in the efficacy parameters of both the drugs. The incidence of adverse effects such as bradycardia, headache, nausea, vomiting, hypotension and rash is less with carvedilol.Conclusions: In patients with mild to moderate hypertension, there was no statistically significant difference between efficacy of carvedilol or atenolol with regard to the degree of reduction in BP or the percentage of patients achieving a response to therapy but carvedilol showed a better safety profile when compared to atenolol